Skip links

Tag: drugs

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary

United States Systemic Lupus Erythematosus Market and Competitive Landscape Report 2021-2026 –

The latest research US Systemic Lupus Erythematosus Market and Competitive Landscape Highlights – 2021, provides comprehensive insights into Systemic Lupus Erythematosus pipeline products, Systemic Lupus Erythematosus epidemiology, Systemic Lupus Erythematosus market valuations and forecast, Systemic Lupus Erythematosus drugs sales and competitive landscape in the US. The research is classified into